ABSTRACT
INTRODUCTION
One of the strategies that contributes to a high rate of success in finding new drug candidates is through ethnopharmacological survey (Fabricant & Farnsworth 2001) . For example, Quassia amara from Simaroubaceae family which is traditionally used as a bitter tonic, to treat fever and ulcers by the natives of South America was discovered to contain several bioactive compounds known as quassinoids and had scientifically shown various potent biological activities including anticancer and antimalarial properties (Bertani et al. 2006; Houel et al. 2009 ).
Chemical and biological research on various genera of the Simaroubaceae plant family such as Ailanthus, Brucea, Eurycoma, Simaba, Quassia and others have also been performed and the biological activities exerted by these plant extracts were found to be contributed by the presence of a group of compounds known as quassinoid (Bhat & Karim 2010; Kundu & Laskar 2010; Lau et al. 2005; Muhammad et al. 2004) . In Sabah and Sarawak of East Malaysia, an indigenous plant identified as Quassia borneensis Noot. has been used traditionally to treat hypertension (Goh et al. 1995) . The plant can be found in primary mixed dipterocarp forest and locally called as mamungal or pait-pait (Kulip & Wong 1995) . However, scientific study has not been performed on this plant to discover its potential biological activities except for the antiplasmodial activity which was recently reported (Ghazali et al. 2013; Wan Razali et al. 2015) .
Realizing the huge potentials of medicinal plants from the Simaroubaceae family for cancer prevention and treatment due to the presence of quassinoids, hence this study was focused on three inhibitory effects on cancer development. An excess production of reactive oxygen species (ROS) and reactive nitrogen species (RNS) at the site of chronic inflammation can lead to cancer. It was suggested that massive release of nitric oxide (NO) by macrophages and chemical reactions of NO with other radicals can generate oxidative and nitrosative stress. This condition will not only cause macromolecular and cellular damages, but also activate transcription factors such as nuclear factor-κB and thus promote tumor development through the regulation of cellular proliferation (Mantovani et al. 2008; Reuter et al. 2010) . Therefore, these mechanisms are important targets for both cancer prevention and treatment.
The objective of this study was to evaluate the antiinflammatory, antioxidant and antiproliferative properties of Q. borneensis bark and root extracts. The findings of biological activities of this plant were aimed to scientifically document the benefits of its traditional application, which later will lead to the discovery of potential chemopreventive agent or chemotherapeutic drug candidate.
MATERIALS AND METHODS

CHEMICALS AND REAGENTS
Lipopolysaccharides (LPS) from Escherichia coli 055:B5, positive control drugs and most chemicals used were purchased from Sigma-Aldrich (USA). Sodium nitrite and 2, 4, 6-Tripyridyl-s-triazine (TPTZ) were purchased from Merck (USA). Ferric chloride (FeCl 3 ) was from HmBG Chemicals (Germany) and dimethyl sulfoxide (DMSO) was from Ajax Finechem (Australia). Primary and secondary antibodies were purchased from Cell Signaling Technology (USA).
PLANT'S SAMPLING AND EXTRACTION
Samples of the plant were acquired from a fully grown tree and identified by botanist of Forest Research Centre (FRC), Sepilok, Sandakan, Sabah, Malaysia. Herbarium specimen (SAN 152508) was prepared and deposited in the FRC Herbarium. Plant samples were classified to twigs, wood, leave, root and bark before they were processed into powder form and stored in a −15°C chill room.
All chemicals used in plant extraction were of analytical grade from Merck (Germany). About 1 kg of powder form plant samples were defatted in petroleum ether and macerated in methanol for two days before concentrated in vacuo. The concentrated methanol extracts were suspended in 10% (v/v) aqueous methanol and partitioned between n-hexane and chloroform. The pooled extracts of hexane and chloroform were concentrated in vacuo producing hexane and chloroform extracts. The aqueous portions were freeze-dried to acquire aqueous extracts. These extracts were labeled as Q. borneensis macerated extracts. Another batch of extraction was carried out in soxhlet apparatus glassware for 24 h and the extracting procedure was followed accordingly. These hexane, chloroform and aqueous extracts were labeled as Q. borneensis soxhlet extracts. The properties of extracts produced were summarized in Table 1 . Murine macrophage RAW 264.7 cells (1 × 10 5 cells/ml) were seeded in 96-well plate overnight and treated with 0.125−1.0 µg/ml Q. borneensis extracts for 2 h before LPS (1 µg/ml) was added. After 24 h treatment with Q. borneensis extracts at 37°C and 5% CO 2 , production of nitrite, the stable conversion product of nitric oxide was determined by Griess assay (Green et al. 1982) . Briefly, 100 µl of culture media was transferred to another 96-well plate and mixed with 100 µl of Griess reagent (1% sulfanilamide, 0.1% naphthalenediamine dihydrochloride) and incubated for 10 min at room temperature in dark. Color development was read at 570 nm by microplate reader (Bio-Rad, USA). Sodium nitrite (0-100 µM) was used to generate the standard curve. Indomethacin, the non-steroidal antiinflammatory drug was used as positive control. Cytotoxic effect of the extracts on RAW 264.7 cells was determined using MTT assay (Mosmann 1983 ) before the experiment conducted.
WESTERN BLOT ANALYSIS RAW 264.7 (1 × 10 5 cells/ml) cells were treated with CSR chloroform extract at concentration of 0.125−1.0 µg/ml in 100 mm culture dish for 2 h and then stimulated with LPS (1 µg/ml). After 24 h incubation, cells were harvested and lysed in RIPA lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, phosphatase and protease inhibitors). After boiling for 5 min, the protein samples (20 µg) were separated by SDS-PAGE on 12% resolving gel and transferred onto polyvinylidene fluoride membranes. The membranes were blocked with 5% skimmed-milk for 1 h and then incubated with iNOS antibody (1:5000) or β-actin antibody (1:10000) overnight at 4°C. Primary antibodies were removed by washing the membranes three times in TBST and then the membranes were incubated for 1 h with horseradish peroxidase conjugated secondary antibody (Xie 2001) . Detection was performed using enhanced chemiluminescence reagent (Amersham™ ECL™ Select, GE Healthcare, UK) and images were analyzed using Fusion-Capt Advance (Fusion FX7, Vilber Lourmat, Germany).
MEASUREMENT OF ANTIOXIDANT CAPACITY
The Ferric Reducing Antioxidant Power (FRAP) assay was carried out to determine the antioxidant capacity of various extracts of Q. borneensis with slight modifications from Benzie & Strain (1996) . The assay was performed in the presence and absence of cells as described by Hasiah et al. (2011) . Concentration of Q. borneensis extracts tested was 6.25-100 µg/ml. In the presence of cells, HL-60 cells (2 × 10 5 cells/ml) were seeded in 96-well plate and treated with various concentrations of extract at 37°C and 5% CO 2 . After 2 h incubation, the plate was sonicated for 30 seconds. Then, freshly prepared FRAP reagent (300 mM acetate buffer, pH 3.6, 20 mM FeCl 3 , 10 mM TPTZ) was added and the plate was incubated for 5 min in dark. The absorbance at 595 nm was measured by microplate reader (Bio-Rad, USA). FeSO 4 .7H 2 O solution (100-1000 µM) was used to generate calibration curve and 100 µM L-ascorbic acid was used as positive control. The antioxidant capacity of the sample was calculated using the FeSO 4 ·7H 2 O calibration curve and expressed as FRAP value (µM FeSO 4 ·7H 2 O equivalent).
CELL PROLIFERATION ASSAY
Antiproliferative activity of Q. borneensis towards HL-60 cells was determined from its viability percentage by MTT assay (Mosmann 1983) . The concentration of Q. borneensis extracts tested was 6.25-100 µg/ml. Briefly, HL-60 cells (2 × 10 5 cells/ml) were seeded and treated with various concentrations of Q. borneensis extracts for 48 h at 37°C in 5% CO 2 . Then, 20 µl of freshly prepared MTT (3-(4, 5-dimethylthiazol-2-yl)-2-5-diphenyl tetrazolium bromide) solution (5 mg/ml) was added into each well in dark. The culture plate was then incubated for another 4 h and the formazan crystal formed was dissolved with DMSO. The plate was incubated for 15 min and shaken for 5 min using vortex mixture. Absorbance at 570 nm was measured using microplate reader (Bio-Rad, USA). Etoposide was used as positive control. The percentage of cell viability was calculated by dividing the sample absorbance with negative control absorbance and multiplied by 100%.
STATISTICAL ANALYSIS
The results were expressed in mean ± SD from three independent experiments. Graphs were constructed with SEM error bars. The data were analyzed using Statistical Package for the Social Sciences (SPSS) software version 20. Differences in mean values between groups were analyzed by one-way ANOVA followed by post-hoc test. Statistical significant was considered at p < 0.05.
RESULTS ANTIINFLAMMATORY ACTIVITIES OF Q. borneensis EXTRACTS
Quassia borneensis hexane, chloroform and aqueous extracts showed different degrees of cytotoxicity to RAW 264.7 cells. For the screening purpose, the highest treatment concentration of 1 µg/ml was chosen for all extracts because it was able to maintain more than 85% of cell viability after 24 h incubation as measured by MTT assay. Concentration of NO 2 -in culture medium was converted into percentage over control (LPS only).
All the hexane, chloroform and aqueous extracts of Q. borneensis showed significant antiinflammatory activity following 2 h pretreatment before LPS induction except CMR and ASB extracts (Figure 1) . The best inhibitory effects of NO production in LPS-stimulated RAW 264.7 cells was shown by CSR extract which significantly reduced 97.64 ± 0.96% of NO production. Good antiinflammatory activity was also shown by CMB and CSB extracts which inhibited NO by 51.16 ± 2.01 and 61.02 ± 6.58%, respectively. Among hexane extracts, HMB and HSB extracts showed a marked inhibitory effect with 34.82 ± 8.54 and 32.55 ± 10.2% reduction of NO production, respectively. Other extracts give less than 25% of NO inhibition. Indomethacin as a positive control significantly inhibited the NO production by 45.12 ± 2.67%.
When tested at several concentrations ranging from 0.125 to 1.0 µg/ml, CSR extract showed dose-dependent inhibitory effect on NO production (Figure 2) . Western blot analysis demonstrated that the extract was able to suppress iNOS expression at higher concentration (Figure 3) . A slight increase in iNOS expression was detected at lower treatment concentration of CSR extract, but was not significantly different compared to the negative control (p > 0.05). FIGURE 1. Effect of Q. borneensis extracts on NO production in LPS-stimulated RAW 264.7 macrophages for 24 h. Cells were treated with extracts at 1 µg/ml and Indomethacin (IDM) at 100 µM. *p < 0.05; **p < 0.01; ***p < 0.001 compared to control (C).
Abbreviation of extracts-H: hexane; C: chloroform; A: aqueous; M: maceration; S: soxhlet; B: bark; R: root The antioxidant activity of Q. borneensis extracts were determined by FRAP assay which measures the ability of a substance to reduce ferric to ferrous ions. The assay was performed in two conditions; extracts only and extracts incubated with cells. Chloroform extracts demonstrated high antioxidant capacity, followed by aqueous extracts (Figure 4) . The highest FRAP value obtained was given by the CMB extract (181.55 ± 5.98), while the lowest value was given by HMB extract (4.20 ± 0.07). On the other hand, untreated HL-60 cells only produce FRAP value of 0.62 ± 1.32 μM FeSO 4 ·7H 2 O. After 2 h incubation with Q. borneensis extracts, a significant increase (p < 0.05) was observed in the antioxidant capacity for all extracts treatment. Although hexane extracts alone showed low antioxidant activity, but HMB, HMR, HSB and HSR extracts were able to increase cellular antioxidant value with 7.6, 6.2, 10.9 and 4.1 times higher, respectively, when incubated with HL-60 cells. Treatment with AMR aqueous extract also showed 6.7 times significant increase of cellular antioxidant activity of HL-60 cells.
ANTIPROLIFERATIVE ACTIVITIES OF Q. borneensis EXTRACTS
After 48 h of treatment, the IC 50 value which corresponded to the concentration of test substance resulting in a 50% inhibition of cell growth, was determined from the graph of percentage of cell viability versus concentration. All chloroform extracts exhibited the greatest degree of antiproliferative activity on HL-60 cells with the IC 50 value < 10 µg/ml (Table 1) . Surprisingly, AMB aqueous extract also demonstrated a significant activity as chloroform extracts. In addition, ASR aqueous extract showed better inhibition of HL-60 cell proliferation than HSR and HSB hexane extracts based on the IC 50 value obtained. Other extracts were less effective because no IC 50 recorded within the range of treatment concentration. Etoposide was used as positive control and inhibited HL-60 cell proliferation with IC 50 value of 2.4 µg/ml (4 µM).
DISCUSSION
Inhibition of NO production and suppression of its molecular pathway is one of the target mechanisms for cancer prevention (Hofseth 2008) . In the study, the hexane, chloroform and aqueous extracts from bark and root of Q. borneensis were screened for NO inhibitory effects and the most prominent activity was shown by chloroform extract of Q. borneensis root obtained by the Soxhlet method. During the inflammatory responses, NO production was mediated by the inducible nitric oxide synthase (iNOS). This enzyme was not constitutively expressed under physiological condition, but can be stimulated by proinflammatory stimuli such as LPS, TNF-α and IFN-γ (Masini et al. 2010) . It was evident from our results that inhibition of NO production in macrophage by Q. borneensis chloroform root extract was also due to the suppression of iNOS protein expression. Several plants from Simaroubaceae family have been shown to have anti-inflammatory properties. For example, Q. amara extracts showed significant inhibition of iNOS and COX-2 protein through prevention of nuclear translocation of NF-κB (Verma et al. 2009 ). Studies on chemical constituent has identified that few quassinoids such as bruceines B and bruceines E from B. javanica (Liu et al. 2012 ) and ailanthone from A. altissima (Kim et al. 2015) displayed an active inhibitory effects on NO production. However, β-carbolines alkaloids isolated from P. quassioides were contributed to the antiinflammatory activities of the plant extract (Jiao et al. 2011) . Therefore, chemical studies on is needed to elucidate the potential constituents that give the antiinflammarory effects of Q. borneensis extracts.
The Q. borneensis extracts also showed antioxidant activities by two possible mechanisms. Direct measurement of the extracts' antioxidant capacity indicated the chemical structure and reaction of an antioxidant. On the contrary, co-incubation of the extracts with cells represented the biological activity of an antioxidant. The use of cellbased assay was introduced by Wolfe & Liu (2007) using dichlorofluorescin oxidation to measure cellular antioxidant activity. However, measurement of Fe 2+ to Fe 3+ conversion was employed for both conditions in this study to determine the antioxidant properties of Q. borneensis extracts. All extracts demonstrated an increase in antioxidant capacity when incubated with cells compared to the extracts alone. This could be due to the increase in cellular antioxidant because untreated cells showed almost no activity (0.62 μM FeSO 4 ·7H 2 O). The presence of high polyphenolic content in plant extracts was known to possess antioxidant properties and can be extracted with polar organic solvents (Ablat et al. 2013; Dai & Mumper 2010) . This could be the explanation of higher antioxidant activities shown by Q. borneensis chloroform extracts.
It was known that an excess production of reactive oxygen species (ROS) and reactive nitrogen species (RNS) play important role in cancer development. At the site of inflammation, respiratory burst caused massive release of ROS such as superoxide anions (O 2 − ) and hydrogen peroxide (H 2 O 2 ). NO is chemically unreactive, but can react with these molecules and produce a powerful oxidant, peroxynitrite (ONOO − ), nitrogen dioxide (NO 2 ) and nitrogen trioxide (N 2 O 3 ). Damage to surrounding tissues cause by these radical molecules will trigger more infiltration of inflammatory cells and activate signaling pathway linked to inflammation and cell proliferation such as NF-κB. In turn, NF-κB activation will lead to upregulation of iNOS expression and therefore producing more NO (Reuter et al. 2010 ). In addition, Q. borneensis extracts specifically the chloroform extracts demonstrated good antiproliferative activity towards HL-60 cells. The cytotoxic and inhibition of cell proliferation properties of many Simaroubaceae plants have been extensively studied and linked to the presence of specific quassinoids. For example, several quassinoids have been isolated from Q. amara leaf extracts, however only the simalikalactone D gave a significant cytotoxic activity (Houel et al. 2009 ). The bioactive composition was still not determined in our study, but it is expected that quassinoid contributed to the inhibition of HL-60 cell proliferation as that compound was known for its antileukemic effects (Hitotsuyanagi et al. 2006) .
Findings of this study suggest that Q. borneensis is a valuable medicinal plant with the potential as a source of chemopreventive agent which could be based on its antiinflammatory and antioxidant properties. Q. borneensis can also be further studied to search for a new chemotherapeutic candidate due to its potent antiproliferative activity of the chloroform extracts. Recently, Ag had reported the presence of canthin-6-one alkaloid and five quassinoids which were identified as glaucarubolone, chaparrinone, holacanthone, glaucarubinone and ailanthinone in this species. Although quassinoids are known for its antileukemic and antimalarial activities, determination of chemopreventive and/or chemotherapeutic activities of these compounds will then explain the medicinal properties of Q. borneensis and the mechanism of action involved at the cellular and molecular levels.
CONCLUSION
Q. borneensis extracts particularly the chloroform extracts possess antiinflammatory, antioxidant and antiproliferative properties. Our scientific findings would provide basic information for its medicinal purposes. However, the characterization of the bioactive constituents which include the quassinoid is still needed to discover its therapeutic potential.
